Hyperexcitability of the hippocampal neurons in the synaptic vesicle protein SV2A mutant rats

被引：0
|
作者：
Tokudome, Kentaro [1 ]
Okumura, Takahiro [1 ]
Shimizu, Saki [1 ]
Kunisawa, Naofumi [1 ]
Tomita, Chisato [1 ]
Kitaya, Ryosuke [1 ]
Mashimo, Tomoji [2 ]
Serikawa, Tadao [2 ]
Sasa, Masashi [3 ]
Ohno, Yukihiro [1 ]
机构：
[1] Osaka Univ Pharm Sci, Pharmacol Lab, Takatsuki, Osaka 5691094, Japan
[2] Kyoto Univ, Sch Med, Inst Lab Anim, Sakyo Ku, Kyoto 6068501, Japan
[3] Nagisa Clin, Hirakata, Osaka 5731183, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2013年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：155P / 155P
页数：1
相关论文
共 50 条
  • [1] Increased seizure susceptibility in the synaptic vesicle protein SV2A mutant rats
    Okumura, Takahiro
    Ishihara, Shizuka
    Terada, Ryo
    Shimizu, Saki
    Tokudome, Kentaro
    Tomita, Chisato
    Kitaya, Ryousuke
    Tanaka, Tomoya
    Kunisawa, Naofumi
    Mashimo, Tomoji
    Serikawa, Tadao
    Sasa, Masashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 155P - 155P
  • [2] Increased sensitivity to methamphetamine in synaptic vesicle protein 2A (SV2A)-mutant rats
    Tokudome, Kentaro
    Shimizu, Saki
    Okumura, Takahiro
    Kunisawa, Naofumi
    Kihara, Sana
    Nakashima, Sanae
    Hashimoto, Aduki
    Hiraoka, Yuki
    Fukuda, Kazuki
    Mashimo, Tomoji
    Serikawa, Tadao
    Ohno, Yukihiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 123P - 123P
  • [3] Developmental Expression of Synaptic Vesicle Protein SV2A
    Vendrame, Martina
    Talos, Delia
    Chang, Meayoung
    Jensen, Frances
    NEUROLOGY, 2009, 72 (11) : A347 - A347
  • [4] Preferential increase in the hippocampal synaptic vesicle protein 2A (SV2A) by pentylenetetrazole kindling
    Ohno, Yukihiro
    Ishihara, Shizuka
    Terada, Ryo
    Kikuta, Miki
    Sofue, Nobumasa
    Kawai, Yoshiko
    Serikawa, Tadao
    Sasa, Masashi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 390 (03) : 415 - 420
  • [5] The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
    Lynch, BA
    Lambeng, N
    Nocka, K
    Kensel-Hammes, P
    Bajjalieh, SM
    Matagne, A
    Fuks, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (26) : 9861 - 9866
  • [6] Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
    Crowder, KM
    Gunther, JM
    Jones, TA
    Hale, BD
    Zhang, HZ
    Peterson, MR
    Scheller, RH
    Chavkin, C
    Bajjalieh, SM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) : 15268 - 15273
  • [7] The brain binding site for the antiepileptic drug levetiracetam is the synaptic vesicle protein SV2A
    Lynch, BA
    Lambeng, N
    Nocka, K
    Kensel-Hammes, P
    Bajjalieh, SM
    Matagne, A
    Fuks, B
    EPILEPSIA, 2004, 45 : 21 - 21
  • [8] The Human Synaptic Vesicle Protein, SV2A, Functions as a Galactose Transporter in Saccharomyces cerevisiae
    Madeo, Marianna
    Kovacs, Attila D.
    Pearce, David A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (48) : 33066 - 33071
  • [9] Association between the synaptic vesicle protein SV2A and mesial temporal lobe epilepsy
    Heils, A.
    Elger, C.
    EPILEPSIA, 2006, 47 : 11 - 12
  • [10] Synaptic vesicle protein 2A (SV2A) mediates anticonvulsant effects of levetiracetam in mice
    Kaminski, Rafal
    PHARMACOLOGICAL REPORTS, 2010, 62 : 20 - 21
12345